Details for New Drug Application (NDA): 204041
✉ Email this page to a colleague
The generic ingredient in ZOLMITRIPTAN is zolmitriptan. There are twenty drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the zolmitriptan profile page.
Summary for 204041
Tradename: | ZOLMITRIPTAN |
Applicant: | Ajanta Pharma Ltd |
Ingredient: | zolmitriptan |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 204041
Mechanism of Action | Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists |
Suppliers and Packaging for NDA: 204041
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ZOLMITRIPTAN | zolmitriptan | TABLET;ORAL | 204041 | ANDA | Ajanta Pharma USA Inc. | 27241-021 | 27241-021-68 | 1 BLISTER PACK in 1 CARTON (27241-021-68) / 6 TABLET in 1 BLISTER PACK |
ZOLMITRIPTAN | zolmitriptan | TABLET;ORAL | 204041 | ANDA | Ajanta Pharma USA Inc. | 27241-022 | 27241-022-38 | 1 BLISTER PACK in 1 CARTON (27241-022-38) / 3 TABLET in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2.5MG | ||||
Approval Date: | May 20, 2016 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | May 20, 2016 | TE: | AB | RLD: | No |
Complete Access Available with Subscription